On June 1, Tempus AI Inc. (NASDAQ:TEM) announced the expansion of its GenAI clinical assistant, called Tempus One, with direct integration into electronic health record/EHR systems. This ...

Tempus One is a range of canned wine spritzers which Australian Vintage released in Australia in October 2023, to appeal to a “younger generation of drinkers”. The UK marks its first foray ...

Tempus One is uniquely positioned to offer these new features given the company’s depth and scale of EHR integrations with providers across the U.S.

The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC) jumped 0.4% and 0.6%, respectively. Tempus, a ...

Tempus noted $100 million of the price will be locked up for one year. ... Tempus revenue increased 33% year over year to $180.9 million and its net loss fell to $75.8 million, ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today introduced a suite of new, transformative capabilities ...

Shares of Tempus AI (TEM-2.69%) were skyrocketing 16.5% higher as of 10:39 a.m. ET on Wednesday. The big gain came after the healthcare artificial intelligence (AI) company announced a multiyear ...

CHICAGO, June 01, 2025--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of Tempus One—its ...

Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC ...

Introducing Tempus One in the EHR with Integrated Guidelines. The AI-enabled clinical assistant is available to query patient data across the EHR as well as build custom agents to maximize workflow.